(Q34038773)

30 July 2017

1 reference

title

Anti-idiotype vaccine against cancer (English)

1 reference

30 July 2017

Bhattacharya-Chatterjee M

series ordinal

1

1 reference

PubMed ID

10996628

30 July 2017

Chatterjee SK

series ordinal

2

1 reference

PubMed ID

10996628

30 July 2017

Foon KA

series ordinal

3

1 reference

30 July 2017

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

74

1 reference

30 July 2017

51-58

1 reference

30 July 2017

1

1 reference

The immune response of rabbits tolerant to bovine serum albumin to the injection of other heterologous serum albumins

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Idiotypic immunization induces immunity to mutated p53 and tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Anti-idiotype immunization of cancer patients: modulation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2800%2900249-2

7 January 2021

10.1016/S0165-2478(00)00249-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10996628